GEN Edge met with founder, president, and CEO Laura Niklason to learn about Humacyte’s journey from clinical observation to commercial-scale tissue manufacturer and how the company plans on expanding its mission to help patients worldwide . . .
See More on the Edge
Continue reading this article and more
with a GEN Edge subscription
The post The Matrix Recellularized: Humacyte Manufactures Bioengineered Human Tissues at Commercial Scale appeared first on GEN – Genetic Engineering and Biotechnology News.
